Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP692780.RABZnfN43su8lT5-YvVvOC4AcDWBXOAypQWbtUQlca2FQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP692780.RABZnfN43su8lT5-YvVvOC4AcDWBXOAypQWbtUQlca2FQ130_assertion type Assertion NP692780.RABZnfN43su8lT5-YvVvOC4AcDWBXOAypQWbtUQlca2FQ130_head.
- NP692780.RABZnfN43su8lT5-YvVvOC4AcDWBXOAypQWbtUQlca2FQ130_assertion description "[Among them, the serum level of autoantibody to src-homology 3-domain GRB2-like 1 (SH3GL1) was significantly higher in patients with low-grade glioma than healthy volunteers or high-grade gliomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP692780.RABZnfN43su8lT5-YvVvOC4AcDWBXOAypQWbtUQlca2FQ130_provenance.
- NP692780.RABZnfN43su8lT5-YvVvOC4AcDWBXOAypQWbtUQlca2FQ130_assertion evidence source_evidence_literature NP692780.RABZnfN43su8lT5-YvVvOC4AcDWBXOAypQWbtUQlca2FQ130_provenance.
- NP692780.RABZnfN43su8lT5-YvVvOC4AcDWBXOAypQWbtUQlca2FQ130_assertion SIO_000772 23050879 NP692780.RABZnfN43su8lT5-YvVvOC4AcDWBXOAypQWbtUQlca2FQ130_provenance.
- NP692780.RABZnfN43su8lT5-YvVvOC4AcDWBXOAypQWbtUQlca2FQ130_assertion wasDerivedFrom befree-20150227 NP692780.RABZnfN43su8lT5-YvVvOC4AcDWBXOAypQWbtUQlca2FQ130_provenance.
- NP692780.RABZnfN43su8lT5-YvVvOC4AcDWBXOAypQWbtUQlca2FQ130_assertion wasGeneratedBy ECO_0000203 NP692780.RABZnfN43su8lT5-YvVvOC4AcDWBXOAypQWbtUQlca2FQ130_provenance.